CStone Reports CS2009 Data From More Than 300 Patients at ESMO 2026
CStone says data from more than 300 patients support CS2009’s mechanism, safety and broad antitumor activity.
CStone says data from more than 300 patients support CS2009’s mechanism, safety and broad antitumor activity.